UGT1A1 genotyping in patients undergoing treatment with irinotecan.
Innocenti
Federico
F
University of Chicago, USA.
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005838:Genotype; D014453:Glucuronosyltransferase / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D000077146:Irinotecan; D009369:Neoplasms / Q000188:drug therapy*; D011110:Polymorphism, Genetic / Q000235:genetics; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012189:Retrospective Studies; D000099148:UGT1A1 Enzyme
D000972:Antineoplastic Agents, Phytogenic; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme